This online meeting, hosted by EHDN, is geared towards a professional audience.
The meeting will include key findings from the Phase III GENERATION HD1 trial, followed by Q&A, then a
panel discussion with recognised experts in the field of HD. The meeting will last approximately 90 minutes.